Protopapas Adonis A, Stournaras Evangelos, Neokosmidis Georgios, Stogiannou Dimitrios, Filippidis Athanasios, Protopapas Andreas N
First Propaedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece (Adonis A. Protopapas, Evangelos Stournaras, Georgios Neokosmidis, Dimitrios Stogiannou, Athanasios Filippidis, Andreas N. Protopapas).
Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom (Evangelos Stournaras).
Ann Gastroenterol. 2020 Jul-Aug;33(4):366-373. doi: 10.20524/aog.2020.0494. Epub 2020 May 15.
Sedation in gastrointestinal endoscopy is rapidly evolving worldwide. However, this has led to significant disagreements, especially regarding the use of propofol by non-anesthesiologists. The aim of this study was to document the practices of Greek gastroenterologists regarding sedation and compare them to previous surveys.
The study was conducted in 2 periods, December 2015 and June 2018. In each period, the same online questionnaire regarding endoscopic sedation practices was sent to all registered Greek gastroenterologists (509 and 547 gastroenterologists, respectively).
The response rates were 38.3% and 47.1%, respectively. In each period, 25.1% and 16.7% of physicians did not use sedation. Most gastroenterologists (approx. 70% in both instances) answered that they "almost never" collaborate with an anesthesiologist during endoscopy. Midazolam was by far the most popular sedation agent, used by almost 90% of physicians in both periods. Propofol was used by 30.8% and 27% of physicians, respectively. Physicians using propofol were significantly more satisfied with the sedation than other physicians, while propofol was the agent selected by most physicians if they were to undergo endoscopy themselves. Most physicians cited medicolegal reasons and inadequate training as chief reasons for not using propofol.
Sedation use is widespread among Greek gastroenterologists. Although midazolam is the most commonly used agent, propofol is preferred (theoretically) by most physicians and achieves the best satisfaction. The introduction of a strict training curriculum for endoscopic sedation can effectively eliminate the barriers preventing gastroenterologists from administering propofol, while at the same time ensuring optimal patient safety during endoscopy.
全球范围内,胃肠内镜检查中的镇静技术正在迅速发展。然而,这引发了重大分歧,尤其是在非麻醉科医生使用丙泊酚方面。本研究的目的是记录希腊胃肠病学家在镇静方面的做法,并与之前的调查结果进行比较。
研究分两个阶段进行,分别为2015年12月和2018年6月。在每个阶段,向所有注册的希腊胃肠病学家(分别为509名和547名胃肠病学家)发送了关于内镜镇静操作的相同在线问卷。
回复率分别为38.3%和47.1%。在每个阶段,分别有25.1%和16.7%的医生未使用镇静剂。大多数胃肠病学家(两个阶段均约为70%)回答说,他们在内镜检查期间“几乎从不”与麻醉科医生合作。到目前为止,咪达唑仑是最受欢迎的镇静剂,两个阶段中几乎90%的医生都使用它。分别有30.8%和27%的医生使用丙泊酚。使用丙泊酚的医生对镇静的满意度明显高于其他医生,而如果他们自己要接受内镜检查,丙泊酚是大多数医生选择的药物。大多数医生将法律医学原因和培训不足作为不使用丙泊酚的主要原因。
镇静剂在希腊胃肠病学家中广泛使用。虽然咪达唑仑是最常用的药物,但大多数医生(理论上)更喜欢丙泊酚,并且丙泊酚能带来最高的满意度。引入严格的内镜镇静培训课程可以有效消除阻碍胃肠病学家使用丙泊酚的障碍,同时确保内镜检查期间患者的最佳安全。